Syadwa Abdul Shukor

Dr. Syadwa Abdul Shukor


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Hepatic Oncology
Verified
Journal Article
Open access
GAGokula Kumar Appalanaido
Gokula Kumar Appalanaido
MAMuhamad Zabidi Ahmad
Muhamad Zabidi Ahmad
SSSyadwa Abdul Shukor
Syadwa Abdul Shukor
AHAlex Khoo Cheen Hoe
Alex Khoo Cheen Hoe
MSManisekar K Subramaniam
Manisekar K Subramaniam
MAMohd Zahri Abdul Aziz
Mohd Zahri Abdul Aziz
Materials & methods: High dose rate interstitial brachytherapy (HDR-IBT) treatment plan for 15 metastatic liver lesions in a patient with pancreatic cancer was retrieved and analyzed for liver dose...


30 December 2021 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Open access
PDF file
RAreduan abdullah
reduan abdullah
GAGokula Kumar Appalanaido
Gokula Kumar Appalanaido
SSSyadwa Abdul Shukor
Syadwa Abdul Shukor
HZHafiz Zin
Hafiz Zin
MAMohd Zahri Abdul Aziz
Mohd Zahri Abdul Aziz
NINorhafizah Ishak
Norhafizah Ishak
Background: This dosimetric study compared lateral wedge with medial only cardiac shielding (LEMONADE) technique, for left chest wall (LCW) irradiation against three other commonly used techniques. Materials and methods: Dosimetric parameters of 22 consecutive LBC patients treated using the P1 (LEMONADE technique) were compared with 3 other virtually reconstructed plans: no cardiac shielding with paired wedges; P2 (paired wedges and medial only Y-direction shielding) and P3 (paired wedges and bilateral Y-direction shielding). Results: P1 showed better target volume (TV) coverage with the mean 90% isodose coverage of 85.59% ± 5.44 compared to 78.90% ± 8.59 and 74.22% ± 9.50 for P2 and P3, respectively. Compared to no cardiac shielding, for a 4.65% drop in TV coverage the V26Gy of heart dropped from 6.68% to a negligible 0.85% for P1. TV receiving < 30Gy is also significantly lesser for P1 compared to P2 and P3 (5.42% vs 10.64% and 15.8%), whilst there is a small difference of 2.75% between no cardiac shielding and P1. Conclusion: With the improvement in BC survival rate, cardiac toxicity associated with adjuvant irradiation for LBC is a major concern. P1 (LEMONADE) technique has a good compromise between cardiac sparing and target coverage and should suffice for most LCW irradiations. Furthermore, the LEMONADE technique is a simple, reproducible and involves fast planning for cardiac sparing, which is ideal for under-resourced departments with heavy workload. Background: This dosimetric study compared lateral wedge with medial only cardiac shielding (LEMONADE) technique, for left chest wall (LCW) irradiation against three other commonly used techniques. Materials and methods: Dosimetric parameters of 22 consecutive LBC patients treated using the P1 (LEMONADE technique) were compared with 3 other virtually reconstructed plans: no cardiac shielding with paired wedges; P2 (paired wedges and medial only Y-direction shielding) and P3 (paired wedges and bilateral Y-direction shielding). Results: P1 showed better target volume (TV) coverage with the mean 90% isodose coverage of 85.59% ± 5.44 compared to 78.90% ± 8.59 and 74.22% ± 9.50 for P2 and P3, respectively. Compared to no cardiac shielding, for a 4.65% drop in TV coverage the V26Gy of heart dropped from 6.68% to a negligible 0.85% for P1. TV receiving < 30Gy is also significantly lesser for P1 compared to P2 and P3 (5.42% vs 10.64% and 15.8%), whilst there is a small difference of 2.75% between no cardiac shielding and P1. Conclusion: With the improvement in BC survival rate, cardiac toxicity associated with adjuvant irradiation for LBC is a major concern. P1 (LEMONADE) technique has a good compromise between cardiac sparing and target coverage and should suffice for most LCW irradiations. Furthermore, the LEMONADE technique is a simple, reproducible and involves fast planning for cardiac sparing, which is ideal for under-resourced departments with heavy workload.

1 January 2021
Verified
Open access
GAGokula Kumar Appalanaido
Gokula Kumar Appalanaido
SSSyadwa Abdul Shukor
Syadwa Abdul Shukor
AFAng Soo Fan
Ang Soo Fan
SCSoon Eu Chong
Soon Eu Chong
HHHasma Hussin
Hasma Hussin
MAMohd Zahri Abdul Aziz
Mohd Zahri Abdul Aziz
Brachytherapy (BT) is an important local treatment of tumor and it can be applied to different anatomical sites either in a curative or palliative setting. BT can deliver large dose of radiation to the tumor while sparing the surrounding normal tissue which translates into a better therapeutic ratio compared to external beam radiotherapy. However, the evidence for the use of brachytherapy in the palliative setting is lacking in the literature. In this case report, we describe the brachytherapy technique and outcome of a patient with squamous cell carcinoma of the hypopharynx who underwent palliative brachytherapy to the hypopharynx and metastatic tumor at the right axilla.

14 March 2023 in Oral Oncology Reports
Verified
Journal Article
Open access
SSSyadwa Abdul Shukor
Syadwa Abdul Shukor
MMMuhammad Yusri Musa
Muhammad Yusri Musa
GAGokula Kumar Appalanaido
Gokula Kumar Appalanaido